Cytokinetics EVP Fady Ibraham Malik reports sale of 3,500 shares for $181,227
CYTK•Cytokinetics EVP Research & Development Fady Ibraham Malik sold 3,500 common shares for $181,227 on Nov. 17, 2026, after exercising options for the same number of shares.
1. Sale and option exercise
Malik sold 3,300 shares at $51.73 each and 200 shares at $52.59 each on Nov. 17, 2026. He also exercised non-qualified stock options for 3,500 shares at $7.80 each. Following the transactions, he held 153,902 common shares directly and had 9,386 non-qualified stock options remaining.




